Home Cart 0 Sign in  

[ CAS No. 51576-04-6 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
Chemical Structure| 51576-04-6
Chemical Structure| 51576-04-6
Structure of 51576-04-6 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 51576-04-6 ]

Related Doc. of [ 51576-04-6 ]

Alternatived Products of [ 51576-04-6 ]

Product Details of [ 51576-04-6 ]

CAS No. :51576-04-6 MDL No. :MFCD00137297
Formula : C6H12O3 Boiling Point : -
Linear Structure Formula :- InChI Key :-
M.W : 132.16 Pubchem ID :-
Synonyms :

Safety of [ 51576-04-6 ]

Signal Word: Class:
Precautionary Statements: UN#:
Hazard Statements: Packing Group:

Application In Synthesis of [ 51576-04-6 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Downstream synthetic route of [ 51576-04-6 ]

[ 51576-04-6 ] Synthesis Path-Downstream   1~2

  • 1
  • [ 73-32-5 ]
  • (2S,3S)-2-Hydroxy-3-methylpentanoic acid [ No CAS ]
YieldReaction ConditionsOperation in experiment
99% With sulfuric acid; sodium nitrite In water at 0 - 20℃; 2S-Hydroxy-3S-methylpentanoic acid (D).4 L-isoleucine (10.0 g, 76.2 mmol) was dissolved in 1 M H2SO4 (200 mL) and the solution cooled to ~0 °C using an ice-water bath. Sodium nitrite (42.1 g, 610 mmol) was dissolved in water (200 mL) and then slowly added to the cold stirred amino acid solution over 4 hours. The reaction was allowed to warm to ambient temperature and the mixture continued to stir for 18 h. The aqueous solution was then saturated with sodium chloride, transferred to a separation funnel and extracted with EtOAc (3×75 mL). The combined organic layers were washed with water (2 × 20 mL) and brine (2×20 mL), dried over anhydrous sodium sulfate. Removal of solvent under reduced pressure gave D in ~99% (9.97 g)
92% With sulfuric acid; sodium nitrite at 0 - 20℃; for 18h;
92% With sulfuric acid; water; sodium nitrite at 60℃; Flow reactor;
89% With cis-nitrous acid
82% With sulfuric acid; sodium nitrite In water at 0℃; for 4h;
79% With sulfuric acid; sodium nitrite
79% With sulfuric acid; sodium nitrite In water at 0℃; for 2h;
76% Stage #1: L-isoleucine With sulfuric acid; sodium nitrite In water at 0℃; for 1.16667h; Stage #2: In water at 20℃; for 70h;
71% With sulfuric acid; sodium nitrite In water at 0 - 20℃;
65% With sulfuric acid; water; sodium nitrite at 0 - 20℃; for 17h; 4.3. Preparation of (S)-2-hydroxy-4-methylpentanoic acid 2c and (2S,3S)-2-hydroxy-3-methylpentanoic acid 2d General procedure: To a stirred and cooled to 0 °C, solution of l-leucine or l-iso-leucine (24.92 g, 0.189 mol) in 1.25 M H2SO4 (125 mL), a solution of sodium nitrite (19.73 g, 0.286 mol) in H2O (100 mL) was added dropwise. Next the mixture was stirred at 0 °C for 2 h and then at room temperature for 15 h. After this time, the contents of the flask were extracted with ethyl ether (6 × 75 mL). The organic layer was dried over MgSO4 and diethyl ether evaporated to yield the appropriate crude α-hydroxycarboxylic acid 2c or 2d, which was purified by recrystallization from hexane-ethyl ether mixture.
60% With sulfuric acid; sodium nitrite In water for 12h;
59% With sulfuric acid; sodium nitrite 0 deg C, 2 h, room temperature, 16 h;
57% With sulfuric acid; sodium nitrite In water at 0 - 20℃; for 168h; 65 Compound 65a To L-isoleucine (2 g, 15.2 mmol) in 1 M H2SO4(aq) (30 mL, 0.5 M) at 0°C was added 2 MNaNO2(aq) (11.5 mL, 22.9 mmol) slowly and the reaction was allowed to warm to rt slowly. Afterdays, the reaction was saturated with (NH4)2S04, extracted with EtOAc (3 x 50 mL), dried overNa2SO4 and concentrated in vacuo to afford 65a (1.25 g, 57%) as a white solid. 1H NMR (400MHz, d6-DMSO): 53.77(d, J=4.9 Hz, 1H), 1.66(m, 1H), 1.40(m, 1H), 1.15 (1 H), 0.84(dd, J15.0, 7.2 Hz, 6H).
57% With sulfuric acid; sodium nitrite In water at 0 - 20℃; for 18h; Cooling with ice; 2-3 Synthesis of Compound 4 7.87 g (60 mmol) of l-Ile was dissolved in ice-cold H2S04 (40 mL, 2.5 mol/L). 6.21 g (90 mmol) of NaNC was dissolved in 30 mL of H20, and was added to the above solution dropwise. The mixture was kept at 0 °C for 2 h, then warmed to rt and stirred for another 16 h. After extraction with EtOAc (200 mL x 1, 100 mL x 3), the combined organic phase was washed with brine (50 mL x 1), dried over Na2S04, and concentrated in vacuo, giving the a-hydroxy acid (4.50 g, 57%) as a colorless oil, which was used for next step without further purification.
52% With sulfuric acid; sodium nitrite In water at 0 - 20℃;
43% With sulfuric acid; sodium nitrite In water
43% With sulfuric acid; sodium nitrite In water stereoselective reaction;
40% With sulfuric acid; water; sodium nitrite for 13h;
21% With tert.-butylnitrite In 1,4-dioxane; water at 20℃; for 1h; Inert atmosphere; α-Hydroxy carboxylic acids General procedure: The Boc-protected amino acid (1 mmol) was treated with TFA (3 mL) for 15 minutes. Afterevaporation the residue was dissolved in dioxane-water (1:1, 4 mL) and the flask wasplaced in an ice bath. tert-Butylnitrite (0.13 mL, 1.1 mmol) was added and stirring wasmaintained under nitrogen at room temperature for one hour. After pouring the reactionmixture onto celite and evaporation (50 Pa, 30 °C) into a dry free-floating powder,separation was performed utilizing a CombiFlash Rf (Teledyne ISCO) automated flashchromatography apparatus by means of AcOH-MeOH-EtOAc (1:9:90) on a normal phasesilica column affording the pure a-hydroxy carboxylic acid in the yield specified in Table 1.HO-His(Bom)-OH and HO-Arg(Tos)-OH were isolated by adding water (30 mL) to thereaction mixture followed by freeze drying and HPLC purification.
Diazotization;
With hydrogenchloride; acetic acid; sodium nitrite
With hydrogenchloride; sodium nitrite In water; acetic acid Ambient temperature;
With sulfuric acid; sodium nitrite at 0℃;
With hydrogenchloride; sulfuric acid; sodium nitrite 2.) EtOH; Yield given. Multistep reaction;
With sulfuric acid; sodium nitrite In water 1.) 0 deg C, 1 h, 2.) room temperature, 12 h;
133 mg With sulfuric acid; sodium nitrite at 0 - 20℃;
With sulfuric acid; sodium nitrite In water at 0℃; for 24h;
Stage #1: L-isoleucine With acetic acid; sodium nitrite In water Stage #2: With potassium carbonate In methanol; water
With hydrogenchloride; sodium nitrite at 0℃; for 6h;
Stage #1: L-isoleucine With acetic acid; sodium nitrite In water at -5 - 0℃; for 3h; Inert atmosphere; Stage #2: With hydrogenchloride; water; methylamine Inert atmosphere;
With perchloric acid; sodium nitrite In water at 0℃; Heating;
17.3 mg With perchloric acid; sodium nitrite In water at 0℃; Reflux;
With perchloric acid; water; sodium sulfite at 0 - 100℃;
Stage #1: L-isoleucine With perchloric acid; sodium nitrite In water at 0 - 20℃; for 1h; Stage #2: In water for 0.05h; Reflux;
With perchloric acid; water; sodium nitrite at 0℃; Reflux;
With perchloric acid; sodium nitrite In water at 0 - 20℃; for 0.5h; 4.6. Preparation of isomers of 2-hydroxyisoleucic acid (Hila) General procedure: L-Isoleucine (100 mg, 0.75 mmol) was dissolved in 50 mL of 0.2 N perchloric acid (0 °C). To this was added a cold (0 °C) solution of NaNO2 (1.4 g, 20 mmol) in 20 mL of H2O with rapid stirring. With continued stirring the reaction mixture was allowed to reach r.t. until evolution of N2 subsided (about 30 min). The solution was then brought to boil for 3 min, cooled to r.t., and saturated with NaCl. The mixture was then extracted with Et2O and dried under vacuum to give 2S, 3S-Hila (L-Hila). The three other stereoisomers 2R,3R-Hila (D-Hila), 2R, 3S-Hila (D-allo-Hila), and 2S, 3R-Hila (L-allo- Hila) were synthesized in a similar manner from D-Ile, D-allo-Ile, and L-allo-Ile, respectively (Mamer, 2000; Mamer and Reimer, 1992).
With sulfuric acid; water; sodium nitrite at 0 - 20℃;
With sulfuric acid; sodium nitrite at 0℃; for 24h;
With sulfuric acid; sodium nitrite In water at 0 - 20℃;
With sulfuric acid; sodium nitrite at 0 - 20℃; for 17h;
With sulfuric acid; sodium nitrite In water at 5 - 20℃; for 26h;
With sulfuric acid; sodium nitrite In water at 5℃;
With perchloric acid; sodium nitrite at 0 - 20℃; for 0.05h; 3.5. Preparation of 2-Hydroxy-3-methylpentanoic Acid (Hmpa) To a stirring solution of L-Ile (10 mg, 0.076 mmol) in 0.2 M perchloric acid (5 mL) was added acold (0 °C) solution of 1 M NaNO2 (2 mL) at 0 °C. With continued rapid stirring, the reaction mixturewas allowed to reach room temperature until evolution of N2 subsided (about 30 min). The solutionwas then boiled for 3 min, cooled to room temperature, and saturated with NaCl before extraction withEt2O and drying under vacuum to give (2S,3S)-Hmpa (L-Hmpa). The three other stereoisomers(2S,3R)-Hmpa (L-allo-Hmpa), (2R,3R)-Hmpa (D-Hmpa), and (2R,3S)-Hmpa (D-allo-Hmpa) weresynthesized in a similar manner from L-allo-Ile, D-Ile, and D-allo-Ile, respectively.
With sulfuric acid; sodium nitrite at 0 - 20℃; The (/yrij-HMP and (i?,i?)-HMP standards were prepared by treating L-isoleucine and D-isoleucine, respectively, with 1 M H2SO4 (0.8 mL) and NaNCh (55 mg) at 0°C. The reactants were stirred for 3 h at 0°C and then stirred overnight at room temperature. Extraction with Et20 provided the crude (L'.L)-HMR and (i?,i?)-HMP products, which were separately stirred overnight with 2-bromo-2'-acetonaphthone (100 mg) and Et3N (50 pL) in 3 mL MeCN. Purification of the products by preparative HPLC (Gemini 5 pm C18 column 250*21.2 mm, 65% MeCN in H2O containing 0.1% TFA) yielded the 2-naphthacyl esters (S.S)- 14a (37 mg) and (i?^?)-14b (39 mg).

Reference: [1]Banasik, Brent A.; Wang, Lee; Kanner, Arielle; Mikael Bergdahl [Tetrahedron, 2016, vol. 72, # 19, p. 2481 - 2490]
[2]Elgersma, Ronald C.; Meijneke, Tania; Posthuma, George; Rijkers, Dirk T. S.; Liskamp, Rob M. J. [Chemistry - A European Journal, 2006, vol. 12, # 14, p. 3714 - 3725]
[3]Hu, Dennis X.; O'Brien, Matthew; Ley, Steven V. [Organic Letters, 2012, vol. 14, # 16, p. 4246 - 4249]
[4]Nozoe, Shigeo; Kikuchi, Kohichi; Ishii, Naoyuki; Ohta, Tomihisa [Tetrahedron Letters, 1992, vol. 33, # 49, p. 7551 - 7552]
[5]Horn, Alexander; Kazmaier, Uli [Organic Letters, 2019, vol. 21, # 12, p. 4595 - 4599]
[6]Lin, Peishan; Ganesan [Bioorganic and Medicinal Chemistry Letters, 1998, vol. 8, # 5, p. 511 - 514]
[7]Guyon, Hélène; Boussonnière, Anne; Castanet, Anne-Sophie [Journal of Organic Chemistry, 2017, vol. 82, # 9, p. 4949 - 4957]
[8]Manaviazar, Soraya; Nockemann, Peter; Hale, Karl J. [Organic Letters, 2016, vol. 18, # 12, p. 2902 - 2905]
[9]Shin; Lee; Lee; Jung; Lee; Yoon [Journal of Organic Chemistry, 2000, vol. 65, # 22, p. 7667 - 7675]
[10]Location in patent: experimental part Poterala, Marcin; Plenkiewicz, Jan [Tetrahedron Asymmetry, 2011, vol. 22, # 3, p. 294 - 299]
[11]Kobayashi, Jun'ichi; Itagaki, Fumio; Shigemori, Ilideyuki; Takao, Toshifumi; Shimonishi, Yasutsugu [Tetrahedron, 1995, vol. 51, # 9, p. 2525 - 2532]
[12]Lloyd-Williams, Paul; Monerris, Patricia; Gonzalez, Isabel; Jou, Gemma; Giralt, Ernest [Journal of the Chemical Society. Perkin transactions I, 1994, # 14, p. 1969 - 1974]
[13]Current Patent Assignee: CYPRALIS LTD - WO2013/185093, 2013, A1 Location in patent: Page/Page column 248
[14]Current Patent Assignee: SMITHSONIAN INSTITUTION - WO2019/104200, 2019, A1 Location in patent: Page/Page column 46-48
[15]Bauer, Tomasz; Gajewiak, Joanna [Tetrahedron, 2004, vol. 60, # 41, p. 9163 - 9170]
[16]Stavrakov, Georgi; Valcheva, Violeta; Philipova, Irena; Doytchinova, Irini [European Journal of Medicinal Chemistry, 2013, vol. 70, p. 372 - 379]
[17]Stavrakov, Georgi; Philipova, Irena; Valcheva, Violeta; Momekov, Georgi [Bioorganic and Medicinal Chemistry Letters, 2014, vol. 24, # 1, p. 165 - 167]
[18]Ikeda, Yoshitaka; Nonaka, Hikaru; Furumai, Tamotsu; Igarashi, Yasuhiro [Journal of Natural Products, 2005, vol. 68, # 4, p. 572 - 573]
[19]Stuhr-Hansen, Nicolai; Padrah, Shahrokh; Strømgaard, Kristian [Tetrahedron Letters, 2014, vol. 55, # 30, p. 4149 - 4151]
[20]Lutz; Jirgensons [Chemische Berichte, 1932, vol. 65, p. 789]
[21]Winitz et al. [Journal of the American Chemical Society, 1956, vol. 78, p. 2423,2428]
[22]Arakawa, Sei'ichi; Nito, Kei'ichi; Seto, Jun'etsu [Molecular Crystals and Liquid Crystals (1969-1991), 1991, vol. 204, p. 15 - 25]
[23]Tabuchi; Ichihara [Tetrahedron Letters, 1992, vol. 33, # 34, p. 4933 - 4936]
[24]Tabuchi; Hamamoto; Miki; Tejima; Ichihara [Journal of Organic Chemistry, 1994, vol. 59, # 17, p. 4749 - 4759]
[25]Hoffman, Robert V.; Tao, Junhua [Journal of Organic Chemistry, 1997, vol. 62, # 7, p. 2292 - 2297]
[26]Mimaki, Yoshihiro; Kuroda, Minpei; Kameyama, Aiko; Yokosuka, Akihito; Sashida, Yutaka [Chemical and Pharmaceutical Bulletin, 1998, vol. 46, # 2, p. 298 - 303]
[27]Zubia, Aizpea; Mendoza, Lorea; Vivanco, Silvia; Aldaba, Eneko; Carrascal, Teresa; Lecea, Begona; Arrieta, Ana; Zimmerman, Tahl; Vidal-Vanaclocha, Fernando; Cossio, Fernando P. [Angewandte Chemie - International Edition, 2005, vol. 44, # 19, p. 2903 - 2907]
[28]Uesusuki, Shinya; Watanabe, Bunta; Yamamoto, Shuji; Otsuki, Junko; Nakagawa, Yoshiaki; Miyagawa, Hisashi [Bioscience, Biotechnology and Biochemistry, 2004, vol. 68, # 5, p. 1097 - 1105]
[29]Yang; Li; Ng; Yan; Qu; Wu [Journal of Organic Chemistry, 2001, vol. 66, # 22, p. 7303 - 7312]
[30]Studte, Christopher; Breit, Bernhard [Angewandte Chemie - International Edition, 2008, vol. 47, # 29, p. 5451 - 5455]
[31]Location in patent: experimental part Simmons, T. Luke; Engene, Niclas; Urena, Luis David; Romero, Luz I.; Ortega-Barria, Eduardo; Gerwick, Lena; Gerwick, William H. [Journal of Natural Products, 2008, vol. 71, # 9, p. 1544 - 1550]
[32]Location in patent: experimental part Choi, Hyukjae; Pereira, Alban R.; Cao, Zhengyu; Shuman, Cynthia F.; Engene, Niclas; Byrum, Tara; Matainaho, Teatulohi; Murray, Thomas F.; Mangoni, Alfonso; Gerwick, William H. [Journal of Natural Products, 2010, vol. 73, # 8, p. 1411 - 1421]
[33]Tripathi, Ashootosh; Puddick, Jonathan; Prinsep, Michele R.; Rottmann, Matthias; Tan, Lik Tong [Journal of Natural Products, 2010, vol. 73, # 11, p. 1810 - 1814]
[34]Location in patent: experimental part Mevers, Emily; Liu, Wei-Ting; Engene, Niclas; Mohimani, Hosein; Byrum, Tara; Pevzner, Pavel A.; Dorrestein, Pieter C.; Spadafora, Carmenza; Gerwick, William H. [Journal of Natural Products, 2011, vol. 74, # 5, p. 928 - 936]
[35]Location in patent: experimental part Simmons, T. Luke; Nogle, Lisa M.; Media, Joseph; Valeriote, Frederick A.; Mooberry, Susan L.; Gerwick, William H. [Journal of Natural Products, 2009, vol. 72, # 6, p. 1011 - 1016] Location in patent: experimental part Thornburg, Christopher C.; Thimmaiah, Muralidhara; Shaala, Lamiaa A.; Hau, Andrew M.; Malmo, Jay M.; Ishmael, Jane E.; Youssef, Diaa T. A.; McPhail, Kerry L. [Journal of Natural Products, 2011, vol. 74, # 8, p. 1677 - 1685]
[36]Location in patent: experimental part Tripathi, Ashootosh; Puddick, Jonathan; Prinsep, Michele R.; Rottmann, Matthias; Chan, Kok Ping; Chen, David Yu-Kai; Tan, Lik Tong [Phytochemistry, 2011, vol. 72, # 18, p. 2369 - 2375]
[37]Wang, Dongyu; Jia, Xian; Zhang, Ao [Organic and Biomolecular Chemistry, 2012, vol. 10, # 35, p. 7027 - 7030]
[38]San Sebastián, Eider; Zimmerman, Tahl; Zubia, Aizpea; Vara, Yosu; Martin, Elyette; Sirockin, Finton; Dejaegere, Annick; Stote, Roland H.; Lopez, Xabier; Pantoja-Uceda, David; Valcárcel, María; Mendoza, Lorea; Vidal-Vanaclocha, Fernando; Cossío, Fernando P.; Blanco, Francisco J. [Journal of Medicinal Chemistry, 2013, vol. 56, # 3, p. 735 - 747]
[39]Wang, Dongyu; Song, Shanshan; Tian, Ye; Xu, Youjun; Miao, Zehong; Zhang, Ao [Journal of Natural Products, 2013, vol. 76, # 5, p. 974 - 978]
[40]Tan, Karen Co; Wakimoto, Toshiyuki; Abe, Ikuro [Organic Letters, 2014, vol. 16, # 12, p. 3256 - 3259]
[41]Yamashita, Tomoya; Kuranaga, Takefumi; Inoue, Masayuki [Organic Letters, 2015, vol. 17, # 9, p. 2170 - 2173]
[42]Jamison, Matthew T.; Molinski, Tadeusz F. [Journal of Natural Products, 2016, vol. 79, # 9, p. 2243 - 2249]
[43]Luo, Danmeng; Putra, Masteria Y.; Ye, Tao; Paul, Valerie J.; Luesch, Hendrik [Marine Drugs, 2019, vol. 17, # 2]
[44]Current Patent Assignee: UNIVERSITY OF OKLAHOMA - WO2020/18888, 2020, A1 Location in patent: Paragraph 0009; 0139
  • 2
  • [ 1460-34-0 ]
  • [ 319-78-8 ]
  • [ 51576-04-6 ]
Same Skeleton Products
Historical Records